Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Maxwell L. Eidinoff is active.

Publication


Featured researches published by Maxwell L. Eidinoff.


Science | 1959

Incorporation of unnatural pyrimidine bases into deoxyribonucleic acid of mammalian cells.

Maxwell L. Eidinoff; L. Cheong; M. A. Rich

When a mammalian cell strain was incubated with 5-iododeoxyuridine and 5-bromodeoxyuridine, DNA thymine was partially replaced by the halogen-containing pyrimidines. The extent of incorporation of the unnatural bases increased when amethopterin and hypoxanthine were added to the medium. It is thus evident that the replacement of DNA thymine by selected structural analogs, a phenomenon previously reported for bacterial systems, is applicable to cells of higher organisms.


Journal of Clinical Investigation | 1955

ISOTOPIC STUDIES OF PLASMA CHOLESTEROL OF ENDOGENOUS AND EXOGENOUS ORIGINS

Leon Hellman; R. S. Rosenfeld; Maxwell L. Eidinoff; David K. Fukushima; T. F. Gallagher; Chun-I Wang; David Adlersberg

This study was undertaken in order to compare the metabolic behavior of plasma cholesterol derived from the diet with that of cholesterol synthesized in vAvo from acetate (1). Cholesterol labeled with either isotopic carbon or hydrogen was administered orally to human subjects and the incorporation into plasma cholesterol was followed over an extended period. In certain instances, both endogenous and exogenous cholesterol metabolism were studied simultaneously by the use of appropriately labeled acetate and cholesterol. These techniques were also applied to an examination of the behavior of plasma cholesterol in four patients with hypercholesterolemia.


Biochimica et Biophysica Acta | 1967

Effect of 5-bromodeoxyuridine on nucleic acid and protein synthesis and viability in HeLa cells

J.H. Kim; A.S. Gelbard; A.G. Perez; Maxwell L. Eidinoff

Abstract 1. A mitotically synchronized population of HeLa cells was exposed to 5-bromodeoxyuridine for 3-h intervals spaced over the entire division cycle. The maximum loss in cell viability took place when the exposure to 5-bromodeoxyuridine occurred during the interval when the rate of DNA synthesis was a maximum. 2. Following a 24-h exposure to the analog, DNA synthesis was inhibited in the subsequent replication cycle whereas RNA and protein synthesis was slightly reduced. 3. The activity of DNA polymerase (deoxynucleoside-triphosphate:DNA deoxynucleotidyltransferase, EC 2.7.7.7) and uridine kinase (ATP:uridine 5′phosphotransferase) was reduced by a significantly large percentage relative to changes in total cellular protein. This may imply alteration in functional protein consequent to the replacement of DNA thymine by 5-bromouracil.


Archive | 1963

Tritium in Biochemical Studies

Maxwell L. Eidinoff

TRITIUM AS A LABEL When a portion of a biochemically interesting compound, such as methyl or phenyl, etc., remains intactthroughout the experiment, then the hydrogens attached to the carbons may serve as a label for the carbons, or for the ring system. In this way, a purine or pyrimidine ring, a steroid framework, the phenyl group of an aromatic amino acid, a portion of fatty acid, has been used, when suitably labeled with tritium, as a marker forthe group in question. This was one of the important uses for deuterium in biochemical systems, as shown in the pioneering work of Schoenheimer, Rittenberg, and numerous other investigators. In the text by Kamen, Radioactive Tracers in Biology, there is a chapter listing compounds containing deuterium and references are given to some applications with these compounds. It is, thus, simply necessary to state that those examples using stably bound deuterium carry over exactly to the use of tritium in those positions.


Journal of the American Chemical Society | 1959

Thiation of Nucleosides. II. Synthesis of 5-Methyl-2'-deoxycytidine and Related Pyrimidine Nucleosides1

Jack J. Fox; Dina Van Praag; Iris Wempen; Iris L. Doerr; Loretta Cheong; Joseph E. Knoll; Maxwell L. Eidinoff; Aaron Bendich; George Bosworth Brown


Cancer Research | 1958

Growth Inhibition of a Human Tumor Cell Strain by 5-Fluorouracil, 5-Fluorouridine, and 5-Fluoro-2′-deoxyuridine—Reversal Studies

Marvin A. Rich; Janice L. Bolaffi; Joseph E. Knoll; Loretta Cheong; Maxwell L. Eidinoff


Cancer Research | 1959

Growth inhibition of a human tumor cell strain by 5-fluoro-2-deoxyuridine: time parameters for subsequent reversal by thymidine.

Maxwell L. Eidinoff; Marvin A. Rich


Endocrinology | 1952

THE FATE OF C14-TESTOSTERONE AND C14-PROGESTERONE IN MICE AND RATS1,2,3

Michael C. Barry; Maxwell L. Eidinoff; Konrad Dobriner


Cancer Research | 1965

Action of 1-β-d-Arabinofuranosyl-5-fluorocytosine on the Nucleic Acid Metabolism and Viability of HeLa Cells

Jae Ho Kim; Maxwell L. Eidinoff; Jack J. Fox


Cancer Research | 1961

Administration of 5-Iododeoxyuridine-I131 in the Mouse and Rat

E. Gambetta Hampton; Maxwell L. Eidinoff

Collaboration


Dive into the Maxwell L. Eidinoff's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Amaury Perez

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

T. F. Gallagher

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jack J. Fox

Université libre de Bruxelles

View shared research outputs
Researchain Logo
Decentralizing Knowledge